Search


In-depth analysis of the potential upcoming sickle cell gene therapy launches with ICER's president
Steve Pearson walks us through the potential demand and accessibility dynamics of these key gene therapy launches.
Jul 28, 2023
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.